Investigating the clinical effect of resveratrol in non-alcoholic fatty liver disease: A randomised, double blind, placebo-controlled trial

被引：0
|
作者：
Chachay, V. S. [1 ]
Martin, J. H. [2 ]
Prins, J. B. [1 ,3 ]
Whitehead, J. P. [3 ]
O'Moore-Sullivan, T. M. [3 ]
Lee, P. [2 ]
Franklin, M.
Klein, K. [4 ]
Taylor, P. J.
Ferguson, M. [5 ]
Coombes, J. S. [5 ]
Thomas, G. P. [1 ]
Cowin, G. J. [6 ]
Kirkpatrick, C. M. J. [7 ]
Macdonald, G. A. [2 ,8 ]
Hickman, I. J. [1 ,3 ]
机构：
[1] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia
[2] Sch Med Metrosouth, Brisbane, Qld, Australia
[3] Mater Med Res Inst, Brisbane, Qld, Australia
[4] Queensland Clin Trials & Biostat Ctr, Brisbane, Qld, Australia
[5] Sch Human Movement Studies, Brisbane, Qld, Australia
[6] Ctr Adv Imaging, Brisbane, Qld, Australia
[7] Monash Univ, Ctr Med Use & Safety, Melbourne, Vic 3004, Australia
[8] Univ Queensland, Dept Princess Alexandra Hospital, Brisbane, Qld, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [1] RANDOMISED, PLACEBO-CONTROLLED CLINICAL TRIAL: LONG-TERM RESVERATROL TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASE
    Heeboll, S.
    Hamilton-Dutoit, S.
    Hellberg, Y. K.
    Stodkilde-Jorgensen, H.
    Jessen, N.
    Pedersen, S. B.
    Gronbaek, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S739 - S739
  • [2] Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
    Heeboll, Sara
    Kreuzfeldt, Martin
    Hamilton-Dutoit, Stephen
    Poulsen, Marianne Kjaer
    Stodkilde-Jorgensen, Hans
    Moller, Holger Jon
    Jessen, Niels
    Thorsen, Kasper
    Hellberg, Ylva Kristina
    Pedersen, Steen Bonlokke
    Gronbaek, Henning
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (04) : 456 - 463
  • [3] Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Chong, Clara Yieh Lin
    Orr, David
    Plank, Lindsay D.
    Vatanen, Tommi
    O'Sullivan, Justin M.
    Murphy, Rinki
    NUTRIENTS, 2020, 12 (04)
  • [4] Quercetin supplementation in non-alcoholic fatty liver disease A randomized, double-blind, placebo-controlled clinical trial
    Hosseinikia, Mahboobe
    Oubari, Farhad
    Hosseinkia, Roghaye
    Tabeshfar, Zibaneh
    Salehi, Mohammad Gharib
    Mousavian, Zeinab
    Abbasi, Mehrnaz
    Samadi, Mehnoosh
    Pasdar, Yahya
    NUTRITION & FOOD SCIENCE, 2020, 50 (06): : 1279 - 1293
  • [5] Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
    Mofidi, Fatemeh
    Poustchi, Hossein
    Yari, Zahra
    Nourinayyer, Babak
    Merat, Shahin
    Sharafkhah, Maryam
    Malekzadeh, Reza
    Hekmatdoost, Azita
    BRITISH JOURNAL OF NUTRITION, 2017, 117 (05) : 662 - 668
  • [6] Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial
    Kessoku, Takaomi
    Imajo, Kento
    Kobayashi, Takashi
    Ozaki, Anna
    Iwaki, Michihiro
    Honda, Yasushi
    Kato, Takayuki
    Ogawa, Yuji
    Tomeno, Wataru
    Kato, Shingo
    Higurashi, Takuma
    Yoneda, Masato
    Kirikoshi, Hiroyuki
    Kubota, Kazumi
    Taguri, Masataka
    Yamanaka, Takeharu
    Usuda, Haruki
    Wada, Koichiro
    Kobayashi, Noritoshi
    Saito, Satoru
    Nakajima, Atsushi
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (11): : 996 - 1007
  • [7] The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
    Faghihzadeh, Forouzan
    Adibi, Payman
    Hekmatdoost, Azita
    BRITISH JOURNAL OF NUTRITION, 2015, 114 (05) : 796 - 803
  • [8] A PLACEBO-CONTROLLED, MULTICENTER, DOUBLE-BLIND, RANDOMISED TRIAL OF EMRICASAN IN SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND RAISED TRANSAMINASES
    Shiffman, M.
    Freilich, B.
    Vuppalanchi, R.
    Watt, K.
    Burgess, G.
    Morris, M.
    Sheedy, B.
    Schiff, E.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S282 - S282
  • [9] Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial
    Kyungsun Han
    Ojin Kwon
    Hyo-ju Park
    So-Young Jung
    Changsop Yang
    Chang-Gue Son
    Trials, 21
  • [10] Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial
    Han, Kyungsun
    Kwon, Ojin
    Park, Hyo-Ju
    Jung, So-Young
    Yang, Changsop
    Son, Chang-Gue
    TRIALS, 2020, 21 (01)
12345